drugset / Trial / NCT01563497

A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State

NCT01563497

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-05089771 tablet.

Timeline

Start
2012-02
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05089771 Small molecule Oral

Indications

No indication recorded.